ArticlePharmaceutics2022

Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study.

Ayman M Al-Qaaneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.